Chen Yao-Long, Zhao Chen, Zhang Li, Li Bo, Wu Chuan-Hong, Mu Wei, Wang Jia-Ying, Yang Ke-Hu, Li You-Ping, Chen Chiehfeng, Wang Yong-Yan, Wang Chen, Bian Zhao-Xiang, Shang Hong-Cai
Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100007, China.
Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, 730000, China.
Chin J Integr Med. 2018 Mar;24(3):163-170. doi: 10.1007/s11655-017-2795-2. Epub 2018 Jan 16.
How to test the treatments of Chinese medicine (CM) and make them more widely accepted by practitioners of Western medicine and the international healthcare community is a major concern for practitioners and researchers of CM. For centuries, various approaches have been used to identify and measure the efficacy and safety of CM. However, the high-quality evidence related to CM that produced in China is still rare. Over the recent years, evidence-based medicine (EBM) has been increasingly applied to CM, strengthening its theoretical basis. This paper reviews the past and present state of CM, analyzes the status quo, challenges and opportunities of basic research, clinical trials, systematic reviews, clinical practice guidelines and clinical pathways and evidence-based education developed or conducted in China, pointing out how EBM can help to make CM more widely used and recognized worldwide.
如何检验中医药疗法并使其更广泛地被西医从业者和国际医疗界所接受,是中医药从业者和研究者主要关心的问题。几个世纪以来,人们采用了各种方法来确定和衡量中医药的疗效与安全性。然而,在中国产生的与中医药相关的高质量证据仍然很少。近年来,循证医学(EBM)已越来越多地应用于中医药领域,强化了其理论基础。本文回顾了中医药的过去与现状,分析了中国开展的基础研究、临床试验、系统评价、临床实践指南、临床路径以及循证医学教育的现状、挑战和机遇,指出循证医学如何有助于使中医药在世界范围内得到更广泛的应用和认可。